Where do new medicines start? They start in the lab, where scientists study the biological mechanisms that contribute to good health or, when they go awry, cause disease. Beaker highlights interesting science, Sanford-Burnham Medical Research Institute and our supporters.
Beaker's Latest Posts
New insights into how harmful molecules accumulate in neurons could lead to novel drug interventions for the most common cause of dementia in older adults.
This is the first Beaker post in a new series to introduce the members of our External Relations team. Today, we spoke with Carol Cox, who joined Sanford-Burnham as Senior Vice President of External Relations a few weeks ago.
FalxonX Rocket launches Bodmer's flies for cardiovascular research.
Scientists at Sanford-Burnham Medical Research Institute (Sanford-Burnham) provide compelling and conclusive evidence that antiestrogen resistance in breast cancer cells requires the interaction between proteins called BCAR1 and BCAR3. In the study, published in the Journal of Biological Chemistry, the researchers also identified a signaling pathway that is crucial for drug resistance mediated by this proteinRead More
April marks the five-year anniversary of the opening of our Lake Nona campus. We’ve achieved a lot over the past five years, but we’re still working hard to understand and find treatments for the most challenging diseases.
Log in to leave a comment